COLUMBIA LABORATORIES INC

CIK 821995 · President and CEO · last filed 2012-03-01

COLUMBIA LABORATORIES INC is a President and CEO who has filed 1 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing, for CBRX, was dated Mar 1, 2012. The firm reports its address in Boston, MA. 27 SEC filings were submitted jointly with DAVID M KNOTT.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

33 ARCH STREET
SUITE 3110
BOSTON, MA 02110

Phone

(617) 639-1500

State of Incorporation

Formerly Known As

COLUMBIA LABORATORIES INC (1995–2015)

Related Filers

DAVID M KNOTT — 27 joint filings, latest 2012-01-31

FRANK CONDELLA JR — 24 joint filings, latest 2016-08-03

EDWARD A BLECHSCHMIDT — 20 joint filings, latest 2014-05-13

STEPHEN G KASNET — 20 joint filings, latest 2014-05-13

MICHAEL MCGRANE — 19 joint filings, latest 2012-03-01

Valerie Lynne Andrews — 17 joint filings, latest 2014-05-13

ROBERT S MILLS — 17 joint filings, latest 2010-03-12

JAMES A GERAGHTY — 14 joint filings, latest 2018-08-15

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CBRX	President and CEO	—	$9.57	—	$0	1	2012-03-01

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2012-03-01	CBRX	Grant (A)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.